mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |